Delivery Order SPE2DB24D1021-SPE2DB24FESXD

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,176.20 firm-fixed-price delivery order contract is for the delivery of WIXELA 250-50 INHUB 60S medical products. The contract has an ultimate completion date of July 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $6,194.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $1,143.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WIXELA 250-50 INHUB 60S, a pharmaceutical product, and has an ultimate completion date of January 17, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,475.53, is a delivery order for the WIXELA 250-50 INHUB 60S pharmaceutical product. The contract has an ultimate completion date of January 29, 2025 and uses a firm fixed-price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,519.44 for the supply of WIXELA 250-50 INHUB 60S medical devices. The award was issued by the Defense Logistics Agency (DLA), which supports the medical needs of the U.S. military and other federal agencies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, with a potential value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,979.33, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of the pharmaceutical product "WIXELA 250-50 INHUB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.16, is a Firm Fixed Price Delivery Order for the supply of WIXELA 250-50 INHUB 60S medical devices. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.72 firm fixed-price delivery order is for WIXELA 250-50 INHUB 60S medical supplies, with a performance period through May 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $1,081.68, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the delivery of the pharmaceutical product WIXELA 250-50 INHUB 60S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to supply the specified medication to support the medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,286.24 firm fixed-price delivery order is for the provision of WIXELA 250-50 INHUB 60S medical products. The contract has an ultimate completion date of November 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FESXD
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,974.95, is a delivery order for the WIXELA 250-50 INHUB 60S medication. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, worth up to $999,999,999, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's critical role in supplying essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, to federal government agencies, particularly the Department of Defense and its military treatment facilities, as well as other federal medical institutions.

Generated 5/17/25, 10:00 AM